ClinicalTrials.gg
Not yet recruitingNCT07882329Updated Oct 20, 2026

Maternal and Fetal Outcomes in Pregnancy With Malignancy

An observational study in Pregnancy Disease and Malignancy, sponsored by Assiut University. Not yet recruiting. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Assiut University · Observational

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
50
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This retrospective study aims to evaluate maternal and fetal outcomes in women diagnosed with malignancy during pregnancy at Assiut University Women's Health Hospital.

Read the detailed description

Cancer complicating pregnancy is a rare but challenging condition requiring multidisciplinary management. Delayed diagnosis and treatment decisions may affect both maternal and fetal outcomes.

This observational study will review medical records of pregnant women diagnosed with malignancy over the last five years to describe maternal oncologic outcomes, pregnancy continuation, delivery outcomes, and neonatal outcomes.

02

Conditions studied

  • Pregnancy Disease
  • Malignancy

Browse trials for

Keywords

  • Cancer in pregnancy
  • Maternal outcomes
  • Fetal outcomes
  • Retrospective
  • Assiut
03

In context

Neoplasms

9,610 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.

This study's planned enrollment of 50 is below the median of 202 across 1,742 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women diagnosed with malignancy and managed at Assiut University Women's Health Hospital during the last five years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Pregnant women diagnosed with any malignancy during pregnancy
  • Managed or followed at Assiut University Women's Health Hospital
  • Complete medical records available

Exclusion criteria

Exclusion Criteria:

  • - Non-pregnant cancer patients
  • Cancer diagnosed postpartum only
  • Incomplete or missing essential data
  • Severe psychological illness
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pregnant Women with Malignancy

    Pregnant women diagnosed with malignancy during pregnancy whose medical records will be reviewed.

06

What researchers measure

Primary outcomes

  1. Number of maternal deaths

    Number of women who died due to malignancy or related complications during pregnancy or follow-up.

    Time frame: Baseline

Secondary outcomes

  1. Number of live births

    Number of pregnancies resulting in live birth.

    Time frame: Baseline

  2. Number of preterm deliveries

    Number of deliveries occurring before 37 weeks of gestation.

    Time frame: Baseline

  3. Number of neonates admitted to NICU

    Number of neonates requiring admission to the neonatal intensive care unit.

    Time frame: Baseline

  4. Birth weight

    Mean birth weight in grams.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07882329
Lead sponsor
Assiut University
Responsible party
Entesar Atef Ramadan (Resident of Obstetrics and Gynecology, Assiut University) — Principal investigator
First posted
Oct 20, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Oct 20, 2027 (estimated)
Completion
Feb 25, 2028 (estimated)
Last update
Oct 20, 2026

Study contacts

Entesar A Ramdan, Resident
Contact
entesaratef2000@gmail.com
+20 10 23495866
Alaa el din M Ismail, prof
study chair · Obstetrics and gynecology Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion